|
|
||||||||
J Thorac Cardiovasc Surg 2004;128:326-327
© 2004 The American Association for Thoracic Surgery
Letter to the editor |
Department of Cardiothoracic Surgery, Castle Hill Hospital, Hull And East Yorkshire Hospitals NHS Trust, Hull, United Kingdom
| The first 20% of the full text of this article appears below. |
To the Editor:
We read with interest the article by Melo and colleagues1 on ventral cardiac denervation (VCD) as a prophylaxis against atrial fibrillation (AF) after coronary revascularization. However, we wish to point out certain aspects of the methodology that may have affected the results. Post-CABG AF is paroxysmal in a large proportion of patients and does not always give rise to clinical symptoms. The fact that only 34% and 33% of the patients in their VCD and control groups, respectively, had continuous telemetry monitoring for 4 days would have significantly reduced the AF detection rate, the primary end point of the study. Although statistically nonsignificant,
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |